Experts discuss the critical challenges in accessing innovative treatments for relapsed refractory multiple myeloma, emphasizing equity and education.
Brooke Adams, PharmD, BCOP
Advertisement
Articles by Brooke Adams, PharmD, BCOP
Experts discuss the evolving role of bispecific antibodies in multiple myeloma, highlighting treatment advancements and strategies for optimal patient care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Fuzuloparib Monotherapy Improves PFS in Advanced Ovarian Cancer, but Adding Apatinib Offers No Additional Benefit
2
Trump Strikes 9 New Pricing Agreements as Drugmakers Navigate Tariff, Regulatory Pressure
3
Top 5 Inflammation Articles of 2025
4
House Republicans Block Vote on ACA Subsidy Extension
5
